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Background: Herpetic necrotizing retinitis is a well-recognized entity. A few cases of herpetic non-necrotizing
retinitis were previously reported.
Findings: We retrospectively report two cases of herpetic non-necrotizing retinopathy with a long follow-up. A
19-year-old woman presented with a bilateral diffuse occlusive retinal vasculitis, peripheral neovascularization, and
no signs of retinal necrosis. Long-lasting immunosuppressive treatment failed to control the vasculitis until herpes
simplex virus type 1 (HSV1) was demonstrated by polymerase chain reaction (PCR) in the aqueous. Acyclovir was
then added and immunosuppressive tapered and eventually stopped resulting in a resolution of vasculitis. Only
two relapses occurred during the next 6 years and responded rapidly to oral acyclovir.
An 11-year-old boy presented with unilateral scar of stromal keratitis, severe vitritis, and optic disc neovascularization,
followed 6 weeks later by peripheral occlusive retinal vasculitis. Therapeutic and diagnostic vitrectomy was performed,
and PCR was found to be positive for varicella zoster virus (VZV) in a vitreous specimen. The inflammation responded
to oral acyclovir therapy. Recurrence of anterior uveitis with iris depigmentation occurred 4 months after treatment was
arrested. After 4 years, he presented again with a recurrence of anterior inflammation and cystoid macular edema
(CME). No sign of inflammation was seen for the next 10 years.
Conclusions: These rare cases support the possible role of herpes viruses (HSV or VZV) in occlusive vasculitis without
retinal necrosis. PCR was useful to raise the diagnosis and to adapt the treatment. A good response was obtained on
oral antiviral therapy.
Keywords: Uveitis; Herpes; Virus; Simplex; Zoster; Retinal necrosis; Polymerase chain reaction; Non-necrotizing; VasculitisFindings
Introduction
Approximately one third of all uveitis cases are asso-
ciated with infectious agents [1], and another third re-
mains with an unknown etiology [2]. Polymerase chain
reaction (PCR) on intraocular fluids is a reliable and
highly sensitive test for the diagnosis of infectious uve-
itis, including cytomegalovirus (CMV), herpes simplex
virus (HSV), and varicella zoster virus (VZV) [3,4].* Correspondence: lcaspers@ulb.ac.be
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in any medium, provided the original work is pSeveral types of herpetic posterior uveitis have been
described. The acute retinal necrosis (ARN) syndrome is
characterized by peripheral retinal necrosis, retinal arter-
itis, and a prominent inflammatory reaction in the vitreous
and anterior chamber of apparently immunocompetent
patients [5]. Progressive outer retinal necrosis syndrome is
also a herpetic retinal necrosis with minimal vitreous in-
flammation occurring in severely immunocompromised
patients [6]. A few cases of herpes virus-related non-
necrotizing posterior uveitis have been described. Bodaghi
et al. described five patients with posterior uveitis unre-
sponsive to steroids and a positive PCR for herpes viruses
(HSV or VZV) in the aqueous. The disease did not re-
spond to conventional therapy with systemic corticoste-
roids and/or immunomodulatory therapy, but favorablen Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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temic antiviral medication [7].
We report two new cases of herpetic non-necrotizing
retinopathy with long follow-up.
Patients and methods
Patient files were retrieved and retrospectively reviewed.
Ophthalmic and systemic data were collected in accor-
dance with the ethic committee of the hospital.
Case 1
A 19-year-old female was referred in September 1993
for the management of an intravitreal hemorrhage in the
right eye, retinal neovascularization of the left eye, and
bilateral retinal vasculitis.
Visual acuity (VA) was 20/20 in both eyes. Anterior
segment examination was normal. Fundus examination
showed severe bilateral occlusive vasculitis (periarteritis
and periphlebitis) with intraretinal hemorrhages and per-
ipheral neovascularization. A diffuse vitreal hemorrhage
was observed in the right eye while it was more preret-
inal in the inferior part of left eye. There was no sign of
retinal necrosis (Figures 1 and 2).
All known causes of ocular vasculitis as sarcoidosis,
presumed tuberculosis-related vasculopathy, systemic lupus
erythematosus, antiphospholipid syndrome, Wegener’s
granulomatosis, Susac’s syndrome, multiple sclerosis,
Behçet’s disease, and syphilis were excluded by an exten-
sive workup. An extensive blood analysis, chest x-ray,
tuberculin skin test, bronchoalveolar lavage, and gallium
scan were performed, but all results returned negative. A
diagnosis of bilateral idiopathic occlusive vasculitis was
raised. Oral corticosteroid therapy was administered, and
laser photocoagulation of the ischemic zones was per-
formed. Therapeutic response remained poor. Therefore,
immunosuppressive agents were added. However, despite
a strong immunosuppressive treatment, multiple recur-
rences of occlusive vasculitis occurred with recurrent
hemorrhages in the posterior pole, mild vitritis, and rare
episodes of anterior chamber inflammation. New ischemic
areas were treated with additional laser photocoagulation.Figure 1 Patient 1: at presentation. Intraretinal hemorrhages and periph
hemorrhage and a chorioretinal scar nasally.After 3 years follow-up, she developed a cystoid macular
edema (CME) in the right eye with VA of 20/25; vision of
the left eye remained 20/20. A therapeutic vitrectomy was
performed in 1996. Despite this treatment, she continued
to develop vasculitis, progressing towards the posterior
pole (Figure 3). In 1998, at recurrence of vasculitis associ-
ated with anterior cells, an anterior chamber paracentesis
was performed, demonstrating HSV 1 by PCR in two
aqueous specimens.
Acyclovir therapy was initiated at the dosage 5 ×
800 mg daily, tapered, and maintained for 7 months, and
immunosuppression was tapered and then arrested. A
rapid healing of the vasculitis was obtained (Figure 4).
Two relapses of retinal vasculitis were reported about 2
and 4 years after the end of oral acyclovir. Both relapses
were treated with oral acyclovir alone (800 mg, 5/day)
for 3 weeks, with rapid resolution of the vasculitis and
no recurrence until the end of the follow-up in November
2004. Final VA was 20/20 in both eyes.
Case 2
In 1999, an 11-year-old boy presented with a unilateral
inferior occlusive retinal vasculitis, optic disc neovascu-
larization, and severe vitritis, limiting the VA of the right
eye to 20/50 at presentation. Slight anterior inflamma-
tion with scars of endothelial and deep stromal keratitis
and inferior pigmented keratic precipitates (KPs) were
also observed in the same eye. Six weeks later, he devel-
oped inferior retinal neovascularization and VA dropped
to 20/200. Because the patient had a tetralogy of Fallot,
the surgeon suspected an endogenous bacterial endoph-
thalmitis, and a diagnostic and therapeutic vitrectomy was
performed with section of the fibrovascular membranes
and photocoagulation of the ischemic non-necrotized pe-
ripheral retina. Evaluation of the vitreous specimens re-
vealed the presence of pigmented macrophages without
any bacteria. Moreover, PCR performed on the vitreous
specimens returned positive for VZV. Oral treatment with
acyclovir (5 × 800 mg daily) was administered and VA im-
proved to 20/50. Diffuse leakage of fluorescein was ob-
served from the posterior and peripheral retina as well aslebitis in both eyes. The right eye shows a diffuse intravitreal
Figure 2 Patient 1: fluorescein angiography at presentation. Diffuse vasculitis and peripheral ischemia of the left eye.
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in the anterior vitreous with CME and hypertony during
the year following vitrectomy, under topical corticoste-
roids and oral acyclovir. Oral acyclovir (800 mg, 5/day)
was administered for 8 months and then replaced by to-
pical acyclovir and topical steroids for another 8 months.
A recurrence of anterior uveitis with posterior iris syne-
chiae and iris depigmentation was observed 4 months
later. The patient was lost from follow-up and came back
in 2003, after 4 years, with an anterior inflammation with
granulomatous inferior KPs of the same eye, slight band
keratopathy, depigmentation of the inferior iris, posterior
iris synechiae, and posterior subcapsular cataract. The
left eye remained normal. The patient was treated with
oral acyclovir (800 mg, 5/day) during 3 weeks and long-
lasting non-steroidal anti-inflammatory drops. Slight
anterior inflammation and CME remained for one more
year. No sign of new active inflammation was seen until
2013. The patient had a final VA of 20/200 (right eye)
and 20/20 (left eye).
Discussion
Case reports of non-necrotizing herpetic uveitis have
been reported very rarely [7,8]. Bodaghi et al. described
five patients with posterior uveitis unresponsive to ste-
roids and whose aqueous aspirates were PCR-positive
for HSV or VZV. The clinical presentation consisted of
retinal vascular involvement, retinal edema, and papilli-
tis. Anterior inflammation was mild or absent. Posterior
segment involvement included features masqueradingFigure 3 Patient 1: fluorescein angiography during immunosuppressi
Despite immunosuppressive treatment, vasculitis remained active in both eas Birdshot retinochoroidopathy, Behçet’s disease, or
idiopathic retinal vasculitis. All patients had chronic
inflammation and no necrotizing forms of herpetic ret-
inopathies that progress as an acute disease (ARN or
PORN) [7].
Other cases of atypical variants of ARN have been
reported, with a slowly progressive ARN and non-
necrotizing forms presenting as vasculitis and/or papil-
litis or panuveitis [8]. A retinal vasculitis has been
described as a complication of primary varicella in an
immunocompetent adult [9]. Recently, a case of purely
occlusive retinal vasculopathy following varicella zoster
infection in an immunocompetent adult, without fea-
tures of vasculitis or anterior and posterior uveitis, has
been published [10]. Chronic herpetic anterior uveitis
with focal or multifocal areas of arteriolar sheathing
without retinal vascular complications has also been
described [11].
We report two new cases of non-necrotizing herpetic
retinopathy characterized by occlusive vasculitis with
initial neovascularization and a good response to anti-
viral therapy. The first patient had a history of bilateral
recurrent posterior inflammation not responding to
steroids and immunosuppressive treatment. This case
occurred long before the first case of herpetic non-
necrotizing retinopathy was described, which delayed
the diagnosis and antiviral treatment. The second pa-
tient presented with a unilateral panuveitis. Both pa-
tients had early retinal neovascularization, which has
not been described previously [7].ve treatment. Retinal photocoagulation was performed in both eyes.
yes.
Figure 4 Patient 1: fluorescein angiography after antiviral treatment. No signs of vasculitis in both eyes after antiviral treatment.
Albert et al. Journal of Ophthalmic Inflammation and Infection  (2015) 5:6 Page 4 of 5A herpetic etiology could be confirmed by PCR analysis
of ocular fluids: case 1 had a positive PCR for herpes sim-
plex virus type 1 (HSV1) on the aqueous while case 2 had
a positive PCR for VZV on the vitreous. Aqueous analysis
was contributory in 86.4% of patients with necrotizing
viral retinopathies [4]. Bodaghi et al. found that DNA
amplification from aqueous could detect VZV and HSV in
non-necrotizing herpetic retinopathies [7].
A remission was obtained in both cases after reaching
the proper etiological diagnosis and initiating antiviral
treatment. However, several recurrences occurred after
arrest of antiviral treatment. The first patient showed re-
lapses of vasculitis after 2 and 4 years, with fast improve-
ment on oral acyclovir. The second patient showed two
recurrences of ipsilateral anterior uveitis. Recurrent anter-
ior uveitis following healed ARN has been reported [12],
but to our knowledge, this is the first case of anterior
uveitis recurrence after non-necrotizing retinopathyFigure 5 Patient 2. Top left: red free photograph of the right eye with res
removed during vitrectomy; top right: red free photograph of the unaffect
leakage of dye from the optic disc and the posterior and peripheral inflamdescribed in the literature. We had previously another pa-
tient with a recurrence of HSV2-related acute anterior
uveitis demonstrated by PCR, several years after a HSV2-
related ARN also demonstrated by PCR (L Caspers, un-
published data). Other types of uveitis tend to recur after
an ARN episode [12,13]. Even multiple occurrences of
ARN separated over long periods can rarely happen in the
same eye [14].
Long-standing preventative antiviral therapy could be
considered for such patients who present with recur-
rences of intraocular inflammation.
Our two cases confirm that herpes virus may cause
non-necrotizing retinopathy with occlusive vasculitis with
early retinal neovascularization. These cases point out the
importance of ruling out all infectious, including viral,
causes in vasculitis, even in the absence of retinal necrosis,
before initiation of immunosuppressive therapy and/or
when patients do not respond to immunosuppressiveidues of the fibrovascular membrane from the optic nerve partially
ed left eye; down: fluorescein angiography of the right eye showing
ed retina.
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first cases of long-term follow-up of non-necrotizing
retinopathy.
Consent
Written informed consent was obtained from the pa-
tients for the publication of this report and any accom-
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